Current Ratio in % of Sigyn Therapeutics, Inc. from Q2 2016 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Sigyn Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2016 to Q3 2025.
Sigyn Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 0.92 %, a 77.9% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	0.92	-3.25	-77.9%	30 Sep 2025
Q2 2025	1.84	-1.8	-49.3%	30 Jun 2025
Q1 2025	2.81	-0.88	-23.8%	31 Mar 2025
Q4 2024	3.35	-2.78	-45.3%	31 Dec 2024
Q3 2024	4.17	-2.36	-36.1%	30 Sep 2024
Q2 2024	3.65	-3.3	-47.5%	30 Jun 2024
Q1 2024	3.69	-4.57	-55.3%	31 Mar 2024
Q4 2023	6.13	-0.32	-4.96%	31 Dec 2023
Q3 2023	6.53	-8.15	-55.5%	30 Sep 2023
Q2 2023	6.95	-38.4	-84.7%	30 Jun 2023
Q1 2023	8.26	-93.5	-91.9%	31 Mar 2023
Q4 2022	6.45	-119	-94.9%	31 Dec 2022
Q3 2022	14.7	-127	-89.6%	30 Sep 2022
Q2 2022	45.3	-115	-71.7%	30 Jun 2022
Q1 2022	102	+53.6	+111%	31 Mar 2022
Q4 2021	126	+94.5	+303%	31 Dec 2021
Q3 2021	141	+109	+332%	30 Sep 2021
Q2 2021	160	+138	+628%	30 Jun 2021
Q1 2021	48.2	+27.5	+133%	31 Mar 2021
Q4 2020	31.1	+11.4	+58.1%	31 Dec 2020
Q3 2020	32.7	+17.2	+110%	30 Sep 2020
Q2 2020	22	+6.1	+38.3%	30 Jun 2020
Q1 2020	20.7	+4.46	+27.5%	31 Mar 2020
Q4 2019	19.7	+2.97	+17.8%	31 Dec 2019
Q3 2019	15.6	-1.71	-9.9%	30 Sep 2019
Q2 2019	15.9			30 Jun 2019
Q1 2019	16.2			31 Mar 2019
Q4 2018	16.7			31 Dec 2018
Q3 2018	17.3			30 Sep 2018
Q3 2016	57.2			30 Sep 2016
Q2 2016	61.7			30 Jun 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.